LIGAND PHARMACEUTICALS INCORPORATED Gain (Loss) on Disposition of Other Assets
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Gain (Loss) on Disposition of Other Assets of $53.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on disposition of other assets for fiscal 2025 was $53.07M.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on disposition of other assets for fiscal 2024 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on disposition of other assets for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED gain (loss) on disposition of other assets for fiscal 2021 was $0.00.
| Period end | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|
| 2025-12-31 | $53.07M 10-K · filed 2026-02-27 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2019-12-31 | $812.80M 10-K · filed 2022-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |